BLT 0.00% 2.6¢ benitec biopharma limited

these are the type of deals we want

  1. 2,381 Posts.
    lightbulb Created with Sketch. 10
    Regulus Therapeutics have a $US600million deal with GSK for up to 4 potential candidates using microRNA.

    http://finance.yahoo.com/news/Regulus-Therapeutics-and-prnews-99230071.html?x=0&.v=1

    BLT and ddRNAi need some industry support soon.

    The lack of any news on progress is not helping the share price, that's for sure.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.